Abstract:Background: At present, the avoidance of drug shortages mainly relies on expert experience. This study aimed to establish an evaluation index system for the risk of drug shortages in medical institutions in China and to apply the system to guide the graded management of drugs in short supply. Methods: A two-round Delphi process was conducted to determine the indicators in the index system. The weight value of each indicator was calculated using analytic hierarchy process (AHP) methods. The data of drugs in short supply from January 1 to December 31, 2020 in Hunan province were collected and evaluated using this index system. The evaluation scores, which ranged from 0 to 100, were calculated. Results: A three-level index system with four first-level indicators, 11 second-level indicators, and 36 third-level indicators was constructed by the two rounds of the Delphi process. The expert authority coefficient (Cr) of the first and second rounds of consultation were 0.88 and 0.90, respectively. The Kendall’s coefficients of concordance (Kendall’s W) for the two rounds of consultation were 0.44 and 0.50, respectively (P<.05). For the first-level indicators ‘supply stability,’ ‘causes of shortage,’ ‘medicine availability in medical institution’ and ‘pharmaceutical properties,’ the weight values were 0.3253, 0.2489, 0.2398, and 0.1860, respectively. Based on the risk evaluation score, drugs (dosage strength) at high risk of shortage included sodium thiosulfate (0.64 g), posterior pituitary lobe hormones (1 mL:6 IU), protamine sulfate (5 mL:50 mg), thrombin (500 U), urokinase (10 WU), and rotundine sulfate (2 mL:60 mg). Conclusion: An indexed system for the risk assessment of drug shortages in China was established to guide the graded response to drug shortages in medical institutions and the implementation of differential management strategies to address these shortages.

Discussion of the Evaluation Index for China's Essential Medicine——A case study of Antilipemic Agents

Evidence-based Research on the Selection Method System for China's Essential Medicine List

CEA Comprehensive Evaluation for Western and Traditional Chinese Hypotensive Drugs

Study on Evaluation Method for the Accessibility of Essential Medicine in China Based on WHO/HAI Standardized Approach

Analysis of Supplementary Provincial Essential Drugs and Their Influential Factors in China

Preliminary Explorotory Study on Essential Medicines List in Shanghai

An Analysis of China's National Essential Medicines Policy

Systems analysis and evaluation of Chinese pharmacoeconomic literatures over ifve years

Investigation and Analysis of the Application of National Essential Drugs and Local Supplemental Drugs in an Area

Empirical Study on Availability of Essential Medicine in China

Investigation and Survey of Essential Drugs Provision and Use in Primary Health Care Institutions from Some Areas in China

Analysis of accessibility of essential medicine in Beijing

Design of an information platform of performance evaluation for essential medicines using system

Analysis of Rational Use of Essential Medicine in Beijing

[Research on evaluation criteria over quality as core index of high grade Chinese patent medicine]

Analysis of the Application of National Essential Drugs in Our Hospital During 2010-2011

Establishment and Application of an Index System for the Risk of Drug Shortages in China: Based on Delphi Method and Analytic Hierarchy Process

Empirical Study on Essential Medicine Price in China

Empirical Study on the Availability of Essential Medicines in Public Health and Medical Institutions of Shang-hai Qingpu District

PHP11 REVIEW OF ADJUSTMENT OF ESSENTIAL MEDICINE LIST AT PROVINCIAL LEVEL IN CHINA

Feasibility Analysis of the Implementation of"307+X"Equipment Module of Essential Medicines among Primary Health Care Institutions in Shanghai